4559:TYO
Zeria Pharmaceutical Co Ltd
JP¥ 1.982,00
arrow_downward
-0,50%(-10,00) 1D
4 sep, 10:24:14 GMT+9 · JPY
search
Alle symbolen
1D
5D
1M
6M
YTD
1J
5J
MAX
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor 4559 genereren…
Openen
JP¥ 1.977
Hoog
JP¥ 1.989
Laag
JP¥ 1.961
Beursw.
99,34 mld.
Gem. vol.
123,73K
Volume
115,40K
Dividend
2,47%
Kwartaaldividend
JP¥ 12
Ex-dividenddatum
29 sep 2026
Koers/winst-verhouding
10,62
52 wk hoog
JP¥ 2.434
52 wk laag
JP¥ 1.878
WPA
JP¥ 187
Uitstaande aandelen
50,11 mln.
Aantal medewerkers
2K
Openen
JP¥ 1.977
Hoog
JP¥ 1.989
Laag
JP¥ 1.961
Beursw.
99,34 mld.
Gem. vol.
123,73K
Volume
115,40K
Dividend
2,47%
Kwartaaldividend
JP¥ 12
Ex-dividenddatum
29 sep 2026
Koers/winst-verhouding
10,62
52 wk hoog
JP¥ 2.434
52 wk laag
JP¥ 1.878
WPA
JP¥ 187
Uitstaande aandelen
50,11 mln.
Aantal medewerkers
2K
Profiel
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Over Zeria Pharmaceutical Co Ltd